Synaptogenix Inc (SNPX)

[Whatsupp]

I have been watching 2-73 for over a year. I still would not touch it with a 10 ft pole. My opinion is that the management is incompetent, except for maximizing his income, the drug has only been given to around 50 patients, it is questionable whether most of the patients even have AD. They have done nothing for an entire year after promising to start several trials, the stock has dropped from $6 to the mid to low $2's. No thanks